AI spots Cancer's genetic secrets in a single cell
NCT ID NCT07410403
Summary
This study is testing a new AI tool designed to analyze pictures of cancer cells from patients with multiple myeloma. The goal is to see if the AI can accurately predict which patients have high-risk genetic abnormalities by looking at the shape and features of their cells. If successful, this method could lead to faster and less expensive genetic testing to help guide treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 410071, China
Conditions
Explore the condition pages connected to this study.